Mechanisms of Refractory Hypertension (Reserpine)

NCT03223272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Refractory Hypertension

Interventions

DRUG: Reserpine

Sponsor

University of Alabama at Birmingham